The global dementia drugs market is anticipated to grow at a significant CAGR of around 8.1% during the forecast period. Dementia is a neurological condition that affects the brain functionality generally more than two functions. Hence, dementia can be correlated with other neurological conditions such as Parkinson’s disease, Alzheimer’s disease, and many more. The factors such as increasing cases of associated conditions of dementia will directly impact the growth of the dementia market during the forecast period. However, the low awareness regarding the dementia condition in developing turns out to be a restraint for the growth of the dementia drugs market. Additionally, the low diagnosis rate will also hamper the growth of the dementia drug market during the forecast period. Moreover, the side effects of dementia drugs such as nausea, vomiting, loss of appetite, sleep problems, feeling of tiredness will lower the popularity of these drugs in the dementia drug market. However, the increasing research for the drug development of dementia as well as its associated conditions will present new growth opportunities to the dementia drug market during the forecast period.
Get Free Sample link @ https://www.omrglobal.com/request-sample/dementia-drugs-market-size
The outbreak of the COVID-19 pandemic is expected to have a considerable impact on the dementia drugs market. In January 2021, the population with dementia is at high risk of contracting COVID-19 infection as the cognitive symptoms cause difficulty to abide by the safety guidelines that were proposed to contain the viral spread.
A full report of Global Dementia Drugs Market available @ https://www.omrglobal.com/industry-reports/dementia-drugs-market-size
- Market Coverage
- Market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others
Market Segmentation
Global Dementia Drugs Market by Dementia Type
- Lewy Body Dementia
- Parkison’s Disease Dementia
- Alzheimer’s Disease Dementia
- Others
Global Dementia Drugs Market by Drugs Type
- Cholinesterase Inhibitors
- MAO Inhibitors
- GlutamateInhibitors
- Others
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- Middle East and Africa
Company Profiles
- Abbvie Inc
- ACADIA Pharmaceutical Inc
- Apotex Corp
- Aurobindo Pharma Ltd
- Biogen Inc
- GlaxoSmithKline Plc
- Johnson & Johnson Services, Inc
- Merck & Co Inc
- Mylan Nv
- Novartis International AG
- Pfizer Inc
- Teva Pharmaceutical Industries Ltd
The report covers
- Market value data analysis of 2022 and forecast to 2028
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global dementia drugs market.
- Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/dementia-drugs-market-size
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
